Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Prostate Cancer Metastatic × apalutamide × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 22 Stage II Prostate Adenocarcinoma 1 Salivary Gland Neoplasms 1 Prostate Cancer Metastatic 1 Metastatic Hormone-sensitive Prostate Cancer 1 Metastatic Castrate-sensitive Prostate Cancer 1

Interventions

apalutamide 1 Standard of Care 1 Radiosurgery 1 Prednisone 1 Docetaxel 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02913196 2025-05-23

Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With mCRPC

Weill Medical College of Cornell University

Phase 1 Active not recruiting

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡